Attending the Vascular Annual Meeting as a scholarship recipient helped turn on a lightbulb in Katharine Wolf’s mind.

In June 2017, the SVS Board of Directors approved bylaw changes that were ratified at the Annual Business Meeting, paving the way to review and approve membership applications throughout the year.

Please Complete Benchmarking Surveys

Curious how vascular services are benchmarked and valued? Wouldn’t you want to have this information to share with your administrators and colleagues?

Despite affecting 25 million Americans, including two to six million with ulcer conditions, chronic venous insufficiency is relatively understudied compared to other vascular diseases. Yet for patients with venous leg ulcers, their condition is debilitating, painful and embarrassing.

Don’t get too comfortable with today’s knowledge on the Quality Payment Program. Some changes are being proposed for 2018, mostly related to increased reporting requirements to avoid the 5 percent Medicare payment penalty in 2020.

News From SVS | First Data Collection Year Coming to an End

SVS members have a narrow window remaining to participate in the Quality Payment Program (QPP) this year and avoid a 4 percent Medicare reimbursement penalty in 2019. The final 90-day reporting period began Oct. 2.

As Executive Director of SVS, one of my priorities, and great joys, is to find opportunities to meet and talk with SVS members locally in their own communities and practices. I hear a lot of ideas expressed at meetings of course, but seeing things first-hand, and talking to partners and team members about their local issues and practice environments and their needs, helps me to understand how SVS can best help. 

CMS Change a Big Victory for Vascular Surgeons, Patients SVS Led Grassroots Effort on Ultrasound Procedures Following a grassroots effort by SVS and in a move that will protect reimbursements for vascular surgeons, the Centers for Medicare and Medicaid Services (CMS) has issued a correction notic

With her research, Omaida C. Velazquez, MD, searches for "what’s missing today that we can make available for tomorrow’s patients." She presented at the 2017 Vascular Research Initiatives Conference, discussing gene therapy and peripheral arterial disease. Abstracts are being accepted through Jan. 10, 2018, for the May 9 conference.

News From SVS

SVS members: have you ever dreamed about planning and running an event to help improve your community’s vascular health?